- Previous Close
7.25 - Open
7.00 - Bid 7.00 x --
- Ask 7.50 x --
- Day's Range
7.00 - 7.30 - 52 Week Range
6.50 - 13.00 - Volume
131,888 - Avg. Volume
139,032 - Market Cap (intraday)
13.74M - Beta (5Y Monthly) 0.21
- PE Ratio (TTM)
-- - EPS (TTM)
-0.00 - Earnings Date Oct 9, 2024 - Oct 14, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Abingdon Health Plc operates as contract research, and contract development and manufacturing organization that develops, manufactures, and distributes diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and for nucleic acid detection. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.
www.abingdonhealth.comRecent News: ABDX.L
View MorePerformance Overview: ABDX.L
Trailing total returns as of 11/22/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ABDX.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ABDX.L
View MoreValuation Measures
Market Cap
13.74M
Enterprise Value
13.35M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.64
Price/Book (mrq)
6.11
Enterprise Value/Revenue
2.18
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-20.72%
Return on Assets (ttm)
-17.93%
Return on Equity (ttm)
-48.69%
Revenue (ttm)
6.13M
Net Income Avi to Common (ttm)
-1.27M
Diluted EPS (ttm)
-0.00
Balance Sheet and Cash Flow
Total Cash (mrq)
1.44M
Total Debt/Equity (mrq)
46.64%
Levered Free Cash Flow (ttm)
-1.52M